Frequently Asked Questions
The market is segmented based on , By Product (Oral Spray, Oral Solution, Oral Liquid, Dissolving Tablets, Gel, and Powder), End- Users (Adult and Paediatric), Distributional Channel (Supermarkets and Hypermarkets, and Others) – Industry Trends and Forecast to 2031.
.
The Global Artificial Saliva Market size was valued at USD 1.25 USD Billion in 2023.
The Global Artificial Saliva Market is projected to grow at a CAGR of 14% during the forecast period of 2024 to 2031.
The major players operating in the market include Cipla, Mission Pharmacal, Fresenius Kabi, Parnell Pharmaceuticals, Forward Science, Laboratorios KIN, ICPA Health Products, NANOCHEMAZONE, Lee BioSolutions, Livealth, GSK, CCMed Group, ENTOD INTERNATIONAL, Midatech Pharma, Valeant Pharmaceuticals International, Biocosmetics Laboratories, Perrigo Company.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America..
